Streetbeat News

Regulatory

LLY

MDGL

NVO

Madrigal Pharmaceuticals' Rezdiffra has shown a strong market entry with $103.3M in Q4 sales. However, competition from GLP-1 drugs by Novo Nordisk and Eli Lilly poses challenges. Madrigal plans to expand Rezdiffra's label to early cirrhosis by 2027, with EMA approval expected in 2025.

Portfolio Pulse from

February 28, 2025 | 7:45 pm

CYTK

Cytokinetics reported a wider-than-expected Q4 loss due to increased operating expenses. The company is focusing on the potential launch of its lead candidate, aficamten, pending FDA approval.

Portfolio Pulse from

February 28, 2025 | 7:30 pm

ITB

Homebuilders are facing a challenging Spring Selling Season in 2025 due to rising costs, policy uncertainty, and high mortgage rates. These factors are impacting the market conditions negatively.

Portfolio Pulse from

February 28, 2025 | 7:15 pm

ICCC

ImmuCell reported a 52% year-over-year sales growth in Q4, improved margins, and is awaiting FDA approval for its product Re-Tain, which is expected to drive further expansion.

Portfolio Pulse from

February 28, 2025 | 7:15 pm

PBA

Pembina Pipeline Corporation has filed its 2024 year-end financial documents, including audited financial statements and Form 40-F, with Canadian and U.S. regulatory authorities.

Portfolio Pulse from

February 28, 2025 | 6:45 pm

XYZ

Block, Inc. (formerly NYSE:SQ, now NYSE:XYZ) is facing a securities class action and fines related to its Cash App platform following a Hindenburg Research report. The report accused Block of overstating user counts and catering to criminals. Investors with losses are encouraged to contact Hagens Berman.

Portfolio Pulse from

February 28, 2025 | 6:45 pm

PPTA

Levi & Korsinsky has initiated an investigation into Perpetua Resources Corp. (NASDAQ:PPTA) for potential violations of federal securities laws. This follows a recent 8-K filing by the company.

Portfolio Pulse from

February 28, 2025 | 6:00 pm

RBGLY

Levi & Korsinsky has initiated an investigation into Reckitt Benckiser Group plc (RBGLY) for potential violations of federal securities laws following a $60 million verdict against the company.

Portfolio Pulse from

February 28, 2025 | 5:45 pm

BABA

GDS

TCEHY

Chinese stocks, including Alibaba, Tencent, and GDS Holdings, fell as President Trump announced additional tariffs on Chinese imports. The Hang Seng Index dropped 3.3%, marking a significant decline.

Portfolio Pulse from

February 28, 2025 | 5:45 pm